Gondek K
Office of Research and Demonstrations, Health Care Financing Administration.
Health Care Financ Rev. 1994 Spring;15(3):1-7.
The articles presented in this issue offer an array of policy-relevant studies in an area that has become increasingly important to both the public and third-party payers. Although it is believed that appropriate utilization of drugs can contribute to containing the growth of health care costs, the impact of appropriate prescribing, dispensing, and use of drugs associated with costs of hospitalizations and physician visits is generally unavailable. As new, ever-more-expensive drugs come to market, comprehensive studies of utilization, expenditures, prices, quality, and cost effectiveness will enhance the policy process.
本期发表的文章提供了一系列与政策相关的研究，该领域对公众和第三方支付者而言都变得越来越重要。尽管人们认为合理用药有助于控制医疗费用的增长，但关于合理开药、配药以及与住院和门诊费用相关的药物使用所产生的影响，目前普遍缺乏相关数据。随着越来越多的新型高价药物进入市场，对药物使用、支出、价格、质量和成本效益进行全面研究将有助于完善政策制定过程。
